GlassScriptPhysician profile
Brian Randolph
NPI 1326615717
$3,518.25
in general payments reported to CMS, 2019-2025
20 companies · $904 in 2025
The $904 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $822 · 2023: $711 · 2024: $799 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,413.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $927.71 | 2021-2025 | Cequa |
| Abbvie INC. | $607.36 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $335.54 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $335.41 | 2021-2025 | Eysuvis, Tryptyr, Clareon |
| Oyster Point Pharma, INC. | $316.69 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb Americas INC. | $236.70 | 2022-2025 | Miebo, Xiidra, Lotemax Sm |
| Coopervision INC. | $169.50 | 2022-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $138.13 | 2021-2023 | Acuvue |
| Dompe US, INC. | $102.55 | 2022-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $69.67 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $63.87 | 2024-2025 | Eylea Hd |
| Eyevance Pharmaceuticals LLC | $42.63 | 2022 | |
| Kala Pharmaceuticals, INC. | $32.23 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $29.77 | 2023 | Syfovre |
| Biotissue Holdings INC. | $22.19 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.03 | 2021 | |
| Aerie Pharmaceuticals, INC. | $19.94 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $17.37 | 2023 | Tecnis Iol |
| Allergan, INC. | $15.01 | 2022 | |
| Oasis Medical, INC. | $13.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Randolph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.